CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies [Phase 2]
Summary
Phase 2 trial evaluating selenium supplementation in adults with moderate-to-severely active ulcerative colitis who are treated with advanced therapies; recruit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: RECRUITING